144 related articles for article (PubMed ID: 26928462)
1. IFNγ-Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2-Mediated Inhibition of Antitumor CTL Responses.
Basingab FS; Ahmadi M; Morgan DJ
Cancer Immunol Res; 2016 May; 4(5):400-11. PubMed ID: 26928462
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
[TBL] [Abstract][Full Text] [Related]
3. Induction of autologous tumor-specific cytotoxic T-lymphocyte activity against a human renal carcinoma cell line by B7-1 (CD8O) costimulation.
Wang YC; Zhu L; McHugh R; Graham SD; Hillyer CD; Dillehay D; Sell KW; Selvaraj P
J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):1-8. PubMed ID: 9147700
[TBL] [Abstract][Full Text] [Related]
4. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
[TBL] [Abstract][Full Text] [Related]
5. The role of intercellular adhesion molecule-1/LFA-1 interactions in the generation of tumor-specific CD8+ T cell responses.
Jenkinson SR; Williams NA; Morgan DJ
J Immunol; 2005 Mar; 174(6):3401-7. PubMed ID: 15749873
[TBL] [Abstract][Full Text] [Related]
6. ICAM-1 and B7-1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM-1.
Deeths MJ; Mescher MF
Eur J Immunol; 1999 Jan; 29(1):45-53. PubMed ID: 9933085
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
[TBL] [Abstract][Full Text] [Related]
8. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
9. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
[TBL] [Abstract][Full Text] [Related]
11. [Expression of major histocompatibility complex antigens and adhesion molecules on renal cell carcinoma cells, and effect of interferon-alpha and/or cimetidine on the expression].
Wu XX; Mizutani Y; Kakehi Y; Nakamura E; Mitsumori K; Takahashi T; Terachi T; Okada Y; Yoshida O
Hinyokika Kiyo; 1998 Sep; 44(9):621-6. PubMed ID: 9805665
[TBL] [Abstract][Full Text] [Related]
12. Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo.
Ahmadi M; Emery DC; Morgan DJ
Cancer Res; 2008 Sep; 68(18):7520-9. PubMed ID: 18794140
[TBL] [Abstract][Full Text] [Related]
13. Importance of IFN-gamma-mediated expression of endothelial VCAM-1 on recruitment of CD8+ T cells into the brain during chronic infection with Toxoplasma gondii.
Wang X; Michie SA; Xu B; Suzuki Y
J Interferon Cytokine Res; 2007 Apr; 27(4):329-38. PubMed ID: 17477820
[TBL] [Abstract][Full Text] [Related]
14. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
Shier P; Ngo K; Fung-Leung WP
J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
[TBL] [Abstract][Full Text] [Related]
15. Intracellular adhesion molecule-1 modulates beta-chemokines and directly costimulates T cells in vivo.
Kim JJ; Tsai A; Nottingham LK; Morrison L; Cunning DM; Oh J; Lee DJ; Dang K; Dentchev T; Chalian AA; Agadjanyan MG; Weiner DB
J Clin Invest; 1999 Mar; 103(6):869-77. PubMed ID: 10079108
[TBL] [Abstract][Full Text] [Related]
16. CD103 or LFA-1 engagement at the immune synapse between cytotoxic T cells and tumor cells promotes maturation and regulates T-cell effector functions.
Franciszkiewicz K; Le Floc'h A; Boutet M; Vergnon I; Schmitt A; Mami-Chouaib F
Cancer Res; 2013 Jan; 73(2):617-28. PubMed ID: 23188505
[TBL] [Abstract][Full Text] [Related]
17. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
18. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
19. Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory.
Scholer A; Hugues S; Boissonnas A; Fetler L; Amigorena S
Immunity; 2008 Feb; 28(2):258-70. PubMed ID: 18275834
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy enhances CXCR3
Wang CL; Ho AS; Chang CC; Sie ZL; Peng CL; Chang J; Cheng CC
Cancer Immunol Immunother; 2023 Jun; 72(6):1865-1880. PubMed ID: 36688994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
